Findings suggest semaglutide and other GLP-1 agonists may significantly reduce alcohol use disorder hospitalizations, warranting further clinical investigation.
GLP-1 drugs, like semaglutide, lower risk of hospitalizations for alcohol use disorder
- Post author:
- Post published:November 18, 2024
- Post category:uncategorized